Journal of Medicinal Chemistry
Volume 40, Issue 15 (July 18, 1997)
Copyright © 1997
American Chemical Society
2289-2292 | Discovery of Potent Nonpeptide Vitronectin Receptor (V3) Antagonists
|
2293-2295 | Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of exo-2-(2'-Fluoro-5'-pyridinyl)-7-azabicyclo- [2.2.1]heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors
|
2296-2303 | Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors
|
2304-2313 | Designing Combinatorial Library Mixtures Using a Genetic Algorithm
|
2314-2322 | Design, Synthesis, and Biological Evaluation of New Growth Inhibitors of Trypanosoma cruzi (Epimastigotes)
|
2323-2334 | Synthesis of Analogs of 2-Methoxyestradiol with Enhanced Inhibitory Effects on Tubulin Polymerization and Cancer Cell Growth
|
2335-2346 | 2-Cyclopropylindoloquinones and Their Analogues as Bioreductively Activated Antitumor Agents: Structure-Activity in Vitro and Efficacy in Vivo
|
2347-2362 | A Novel Series of 2,5-Substituted Tryptamine Derivatives as Vascular 5HT1B/1D Receptor Antagonists
|
2363-2373 | Synthesis and Anti-HIV-1 Activity of a Series of 1-Alkoxy-5-alkyl-6-(arylthio)uracils
|
2374-2385 | 4-Heterocyclylpiperidines as Selective High-Affinity Ligands at the Human Dopamine D4 Receptor
|
2386-2397 | Stabilized Analogs of Thymopentin. 1. 4,5-Ketomethylene Pseudopeptides
|
2398-2406 | Stabilized Analogs of Thymopentin. 2. 1,2- and 3,4-Ketomethylene Pseudopeptides
|
2407-2411 | Stabilized Analogs of Thymopentin. 3. Evaluation of Ketomethylene Pseudopeptides for Antiarthritic Properties
|
2412-2423 | A Virtual Screening Approach Applied to the Search for Trypanothione Reductase Inhibitors
|
2424-2429 | Synthesis of Racemic 6,7,8,9-Tetrahydro-3-hydroxy-1H-1-benzazepine-2,5-diones as Antagonists of N-Methyl-D-aspartate (NMDA) and -Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptors
|
2430-2433 | Novel Non-Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. 6. 2-Indol-3-yl- and 2-Azaindol-3-yl- dipyridodiazepinones
|
2434-2434 | Emerging Drugs. The Prospect for Improved Medicines. Annual Executive Briefing. Volume Two. 1997 Edited by William C. Bowman, J. Desmond Fitzgerald, and John B. Taylor. Ashley Publications Ltd, London. 1997. x + 415 pp. 20.5 × 24 cm. ISSN 1361-9195. $640.00; $385.00 (pbk).
|